bioecon Member area
Technology · Bioproduction & equipment / Cleanroom & facilities

Cold chain for cell & gene therapies

Specialized courier and logistics networks that manage the temperature-controlled, chain-of-identity transport of autologous and allogeneic cell and gene therapy products between collection, manufacturing and patient-administration sites, sold by dedicated advanced-therapy-logistics providers rather than the cryogenic hardware itself.

Medicine & Pharmaceuticals Risk: low Advanced therapies US · CN · EU Science: why it works → verified 2026-08-12 · 4 Sources (0 independent)

1 · What it gives

Cold chain for cell and gene therapies is the logistics service layer that moves a patient’s own cells (autologous) or a donor-derived product (allogeneic) between collection site, manufacturing facility and point of administration, distinct from the cryogenic tanks, freezers and shippers that provide the underlying equipment. For an autologous CAR-T therapy, the same physical unit that leaves a patient as a starting material must return to that same patient as a finished, temperature-critical product — a chain-of-identity requirement layered on top of the chain-of-custody every logistics network must maintain. A specialized courier manages the door-to-door itinerary, customs clearance for cross-border shipments, real-time temperature and location tracking, and contingency response if a flight is cancelled or a shipment is delayed, coordinating between the collection center, the manufacturing site (which may be on a different continent) and the treating hospital. This service layer sits downstream of the cryogenic hardware (EQP-066) and general biospecimen logistics (SVC-134) — it is specifically the advanced-therapy-focused courier and program-management capability, not the tanks and freezers themselves, and not general clinical-trial specimen transport.

The key directions of cold chain for cell and gene therapies are:

  1. Chain-of-identity courier networks: door-to-door logistics providers that track and preserve the one-to-one link between a patient’s starting material and the finished therapy product returned to that same patient.
  2. Advanced-therapy-specific program management: dedicated logistics coordination teams that manage the full itinerary across collection, manufacturing and administration sites, often spanning multiple countries and regulatory jurisdictions.
  3. Real-time temperature and location tracking: connected monitoring across every leg of the shipment, with proactive alerting and contingency response for flight delays or customs holds that could jeopardize product viability.
  4. Cross-border customs and regulatory clearance: specialized import/export handling for biological material, navigating country-specific requirements for temperature- sensitive, patient-specific therapeutic products.

Sectoral value chain#

[Patient/donor collection site] ──> [Chain-of-identity labeling & packaging]
                                                    │
                                          (temperature-controlled courier network)
                                                    │
                                                    ▼
[Patient administration site] <─── [Customs/regulatory clearance] <─── [Manufacturing facility]

Value chain levels#

LevelDescriptionKey inputs/outputs
Collection-site coordinationThe logistics provider coordinates pickup timing and initial packaging at the apheresis or biopsy collection site.In: collected patient/donor material. Out: chain-of-identity-labeled, temperature-packaged shipment.
Chain-of-identity trackingEvery shipment carries a unique identifier linking it to a specific patient, tracked end-to-end regardless of how many legs or handoffs the journey requires.In: labeled shipment. Out: continuously tracked, identity-linked product.
Temperature-controlled transportA specialized courier network manages door-to-door transport, using cryogenic or controlled-ambient packaging matched to the product’s stability profile.In: identity-linked shipment. Out: temperature-validated product in transit.
Customs and regulatory clearanceCross-border shipments require specialized import/export handling for temperature-sensitive, patient-specific biological material.In: in-transit shipment. Out: customs-cleared shipment, regulatory documentation.
Contingency managementReal-time monitoring flags flight delays, customs holds or temperature excursions, triggering a pre-planned contingency response.In: tracking data, excursion alerts. Out: corrective action, updated delivery plan.
Delivery and chain-of-custody documentationThe product reaches the manufacturing or administration site with a complete, auditable chain-of-custody and chain-of-identity record.In: delivered product. Out: GMP-compliant delivery and identity record.

Cross-cutting technologies of the sector:

  • Chain-of-identity software platforms: dedicated tracking systems that link each physical shipment to a specific patient record across every handoff, distinct from general shipment tracking.
  • Multi-modal temperature-controlled routing: logistics networks combine air, ground and cryogenic dry-vapor packaging to match each leg of the journey to the product’s stability window.
  • Proactive contingency protocols: pre-established backup routing and courier redundancy for time- and temperature-critical shipments, reducing the risk that a single flight cancellation jeopardizes an irreplaceable patient-specific product.

2 · What it replaces 0 · matched by industry

No graded substitution linked yet.

3 · How to implement 6 steps

  1. 1
    Collection-site coordination
    The logistics provider coordinates pickup timing and initial packaging at the apheresis or biopsy collection site, initiating the chain-of-identity record.
  2. 2
    Chain-of-identity labeling and packagingPackaging & fill-finish
    The shipment is labeled with a unique identifier linking it to a specific patient and packaged to the temperature-stability requirement of the product.
    Who can do this step matched automatically
    30,000tons industrial scale
    “[Luzhou Pack: Sustainable Food Packaging Manufacturer”
    Ecoware India
    1,500 tons/
    “Our range of 135+ biodegradable and compostable products includes plates, bowls, cups, trays, takeaway containers and custom food packaging solutions trusted by restaurants, cafés, …”
    Hotpack Global United Arab Emirates
    “Founded in 1995, Hotpack is a recognized leader in the manufacturing and supply of food packaging products.”
    RWDC Industries Singapore
    industrial scale
    “2026-04-02 [A Major Step Forward in the Fight Against Microplastics — RWDC Industries is positioning itself as a leader in sustainable biopolymers, specifically Solon PHA, a fully …”
  3. 3
    Temperature-controlled transport
    A specialized courier network manages door-to-door transport, using cryogenic or controlled-ambient packaging matched to the product’s stability profile.
  4. 4
    Customs and regulatory clearanceRegulatory & certification
    Cross-border shipments undergo specialized import/export handling for temperature- sensitive, patient-specific biological material.
    Registration in Russia / EAEU: Regulation
  5. 5
    Contingency management
    Real-time monitoring flags flight delays, customs holds or temperature excursions, triggering a pre-planned contingency response to protect product viability.
  6. 6
    Delivery and documentation

    The product reaches the manufacturing or administration site with a complete, auditable chain-of-custody and chain-of-identity record, meeting 21 CFR Part 210/211 and EU GMP Annex 1 documentation requirements.


4 · Who delivers

Matched suppliers (matched automatically)

Cryoport SystemsUnited StatesProduceractive
NovartisSwitzerlandProduceractive
Lonza GroupSwitzerlandProduceractive
AstraZenecaUnited KingdomProduceractive
Kheiron BiotechArgentinaServices / consultingactive
MinicircleUnited StatesResearch / RTOactive
AGC BiologicsUnited StatesProduceractive
PBS BiotechUnited StatesEquipmentactive
FreseniusGermanyProduceractive
Johnson & JohnsonUnited StatesProduceractive
ANFT (Association of Nature & Forest Therapy)United StatesServices / consultingactive
Becton DickinsonUnited StatesProduceractive

In the services and supply catalogue 2 · paid service

Cleanrooms & process utilities · Engineering, EPC & validation

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
World Courier🇺🇸 USACAR-T and cell/gene therapy logistics programDedicated advanced-therapy courier positioning; long-distance chain-of-identity transportCommercial
Marken🇬🇧 UKAdvanced therapy logisticsPublished cell/gene therapy logistics operations expertise; global networkCommercial
Fisher Clinical Services🇺🇸 USASample and IP logistics for cell/gene therapyPackaging, labeling and cold-chain coordination for global clinical programsCommercial
Cavalier Logistics🇺🇸 USATurn-key cold chain, multi-temperature order handlingBiopharma logistics precision positioningCommercial

5 · Rules & route to market

United States

The US hosts the category’s leading advanced-therapy logistics providers, serving the world’s largest concentration of cell and gene therapy manufacturing and clinical administration sites.

advanced-therapy logistics network depth, chain-of-identity program management leadership#

  • World Courier: positions itself specifically around chimeric antigen receptor (CAR-T) and other cell/gene therapy logistics, with dedicated program messaging around the zero-margin-for-error nature of moving these products across long distances.
  • Cavalier Logistics: provides turn-key cold chain and multi-temperature order handling for biopharma logistics, with dedicated messaging around cold-chain and pharma-logistics precision.
  • Fisher Clinical Services: manages complex sample and investigational-product logistics specifically in support of cell and gene therapy programs, including packaging, labeling and cold-chain coordination for global clinical programs.

European Union

The United Kingdom hosts a global leader in advanced-therapy logistics specifically, with deep specialization in the cell and gene therapy chain-of-identity and program-management capability the category requires.

advanced-therapy logistics specialization, global program-management leadership#

  • Marken (UK): provides dedicated advanced-therapy logistics with published learning-center content specifically on cell and gene therapy logistics operations, positioning the company around the precision required for this therapy class rather than general pharma cold chain.

China

No China-headquartered advanced-therapy logistics provider was screened in this round; demand is driven by China’s expanding cell and gene therapy clinical and commercial base, currently served largely through the same global logistics networks operating in the US and EU.

import- and global-network-served market, domestic cell/gene therapy clinical build-out#

  • Global network coverage: World Courier, Marken and other global advanced-therapy logistics providers maintain China operations serving domestic cell and gene therapy clinical trials and commercial distribution.
  • Domestic cell/gene therapy build-out: China’s growing cell and gene therapy clinical and manufacturing base is the main demand driver for advanced-therapy logistics capacity, without a confirmed domestic chain-of-identity courier network identified in this screen.
  • Screening note: this screen focused on US/EU-headquartered global networks, given their established China operations; a dedicated China-originated candidate was not probed in this round.

6 · Money: tenders & grants

GrantCircularity of seafood supply chain
European Commission · EU
Sep 21, 2027
302 days
GrantEnhancing ecodesign and circularity of construction products
European Commission · EU
Sep 22, 2027
303 days
GrantInnovative circular solutions for end-of-life footwear through collection, sorting and recycling
European Commission · EU
Sep 22, 2027
303 days
GrantOpen topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of …
European Commission · EU
Apr 8, 2027
136 days
GrantReplacing hazardous substances in biocidal products
European Commission · EU
Sep 22, 2027
303 days

7 · Tech stack & innovations

The stack layers chain-of-identity tracking, multi-modal temperature-controlled routing and cross-border regulatory clearance on a common contingency-management backbone.

  1. Chain-of-identity tracking systems:
    • Dedicated software links each physical shipment to a specific patient record across every handoff, a requirement distinct from general shipment tracking because an autologous product must return to the exact same patient it originated from.
    • Tracking persists across collection, manufacturing and administration legs, often spanning multiple couriers, countries and regulatory jurisdictions.
  2. Multi-modal temperature-controlled routing:
    • Logistics networks combine air, ground and cryogenic dry-vapor packaging to match each leg of the journey to the product’s stability window, switching modes as needed to preserve product integrity.
    • Route planning accounts for customs-hold risk and flight-schedule reliability specifically for temperature- and time-critical patient-specific shipments.
  3. Proactive contingency protocols:
    • Pre-established backup routing and courier redundancy reduce the risk that a single flight cancellation or customs delay jeopardizes an irreplaceable patient-specific product.
    • Real-time alerting triggers a pre-planned response the moment a temperature or schedule deviation is detected, rather than after the shipment has already been compromised.

Sources 4 · 0 independent · 4 producer sites

Producers' own sites 4

  1. World courier producer checked 2026-05-05 · link not kept
  2. Marken producer checked 2026-05-18 · link not kept
  3. Cavalier logistics producer checked 2026-08-03 · link not kept
  4. Fisher clinical services producer checked 2026-05-18 · link not kept